EBITDA of Boiron 2012-2024
This statistic illustrates the earnings before interest, taxes, depreciation, and amortization (EBITDA) of the Boiron from 2012 to 2024. In 2024, the EBITDA of Boiron amounted to around 42.7 million euros .
Earnings before interest, taxes, depreciation, and amortization (EBITDA) of Boiron from 2012 to 2024 (in 1,000s of euros)
Loading statistic...
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 5 people
$1,299 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Boiron
Introduction
4
Revenues
3
Geographic distribution
3
Financial data
5
Workforce
4
Further related statistics
16
- After-tax turnover of Boiron laboratories 2012-2019
- OTC revenue of homeopathic remedies in the U.S. 2011-2017
- Sales of homeopathic and herbal remedies in Germany from 2019 to 2023
- OTC sales volume of homeopathic remedies in the U.S. 2011-2017
- Sales volume of over the counter phytopharmaceuticals and homeopathy in Germany 2018
- Revenues from herbal and homeopathic medicine in German pharmacies 2021-2023
- Properties of homeopathy according to the French 2018
- Number of alternative medicine and homeopathy employees in Germany 2012-2023
- Italy: traditional medicine vs homeopathic medicine 2016
- Brazil: number of homeopaths 2013-2018
- Canadians' views on removal of labels on homeopathic remedies by ethnicity 2016
- Pharmacy revenue from OTC medicine in Germany 2023
- Over the counter homeopathic and herbal medicine revenue in Germany 2023
- Testosterone use in the U.S. per 1,000 population 2011
- U.S. public approval of medical marijuana 1995-2015
- Revenue per capita of skin treatment in Singapore 2018-2029
Further Content: You might find this interesting as well
Statistics
- After-tax turnover of Boiron laboratories 2012-2019
- OTC revenue of homeopathic remedies in the U.S. 2011-2017
- Sales of homeopathic and herbal remedies in Germany from 2019 to 2023
- OTC sales volume of homeopathic remedies in the U.S. 2011-2017
- Sales volume of over the counter phytopharmaceuticals and homeopathy in Germany 2018
- Revenues from herbal and homeopathic medicine in German pharmacies 2021-2023
- Properties of homeopathy according to the French 2018
- Number of alternative medicine and homeopathy employees in Germany 2012-2023
- Italy: traditional medicine vs homeopathic medicine 2016
- Brazil: number of homeopaths 2013-2018
- Canadians' views on removal of labels on homeopathic remedies by ethnicity 2016
- Pharmacy revenue from OTC medicine in Germany 2023
- Over the counter homeopathic and herbal medicine revenue in Germany 2023
- Testosterone use in the U.S. per 1,000 population 2011
- U.S. public approval of medical marijuana 1995-2015
- Revenue per capita of skin treatment in Singapore 2018-2029
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 5 people
$1,299 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Boiron. (April 6, 2025). Earnings before interest, taxes, depreciation, and amortization (EBITDA) of Boiron from 2012 to 2024 (in 1,000s of euros) [Graph]. In Statista. Retrieved June 11, 2025, from https://www.statista.com/statistics/1073057/boiron-ebitda/
Boiron. "Earnings before interest, taxes, depreciation, and amortization (EBITDA) of Boiron from 2012 to 2024 (in 1,000s of euros)." Chart. April 6, 2025. Statista. Accessed June 11, 2025. https://www.statista.com/statistics/1073057/boiron-ebitda/
Boiron. (2025). Earnings before interest, taxes, depreciation, and amortization (EBITDA) of Boiron from 2012 to 2024 (in 1,000s of euros). Statista. Statista Inc.. Accessed: June 11, 2025. https://www.statista.com/statistics/1073057/boiron-ebitda/
Boiron. "Earnings before Interest, Taxes, Depreciation, and Amortization (Ebitda) of Boiron from 2012 to 2024 (in 1,000s of Euros)." Statista, Statista Inc., 6 Apr 2025, https://www.statista.com/statistics/1073057/boiron-ebitda/
Boiron, Earnings before interest, taxes, depreciation, and amortization (EBITDA) of Boiron from 2012 to 2024 (in 1,000s of euros) Statista, https://www.statista.com/statistics/1073057/boiron-ebitda/ (last visited June 11, 2025)
Earnings before interest, taxes, depreciation, and amortization (EBITDA) of Boiron from 2012 to 2024 (in 1,000s of euros) [Graph], Boiron, April 6, 2025. [Online]. Available: https://www.statista.com/statistics/1073057/boiron-ebitda/